z-logo
open-access-imgOpen Access
Efficacy of Qurs Kushtae Faulad and Jawarishe Amla in Iron Deficiency Anemia among Women of Reproductive age
Author(s) -
CS Nagesh,
Wajeeha Begum,
Kouser Fathima Firdose
Publication year - 2018
Publication title -
journal of ayurvedic and herbal medicine
Language(s) - English
Resource type - Journals
ISSN - 2454-5023
DOI - 10.31254/jahm.2018.4306
Subject(s) - medicine , anemia , iron deficiency anemia , iron deficiency , pregnancy , pediatrics , iron supplementation , population , iron supplement , obstetrics , environmental health , genetics , biology
Back ground and objective: Anemia is the most widespread nutrient deficiency in the world, most often associated with iron deficiency. The functional consequences of anemia include an increased risk of maternal and perinatal mortality; poor pregnancy outcomes viz. low birth weight and preterm birth. Anemia is a major public health concern globally, especially among women and children. Anemia affects 24.8% of the population, the highest prevalence is among preschool-aged children (47.4%), followed by pregnant women (41.8%) and women of reproductive age. Methods: This randomized, single blind, standard controlled study compared efficacy of qurs kushtae Faulad and jawarishe Amla against cap Fefol on diagnosed subjects of iron deficiency anemia. Test group (n=20) received jawarishe Amla 7g with water and qurs kushtae Faulad (Hamdard) 2 twice a day for 2 months after meals. Whereas control group received cap Fefol 1 bid after meals for 2 months. The primary outcome measure was improvement in Hb% and PCV. Results: Iron deficiency anemia is significantly improved (P <0.001**) after intervention in two groups. There is significant improvement in Hb% with the mean±SD before treatment is 9.68±1.16 and after treatment 11.24±1.51 with p value is <0.001**. The mean±SD of PCV before treatment is 30.36±2.75 and after treatment is 33.92±4.76 with p value of 0.002**, which is more significant clinically and statistically. Interpretation & Conclusion: Test drug provide statistically significant improvement in iron deficiency anemia. It can serve an alternative treatment for Iron deficiency anemia. Further research is certified on large sample size.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here